🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fostering Data Sharing

Search Papers Authors Institutions Grants FAIR About

TheSindex

Fostering Data Sharing

Empowering the data sharing that empowers science — an open, citation-grounded index for datasets.

Product

Search
API
Explore
Rankings

Resources

Methodology
Data Sources
Documentation
Press

Organization

About
Team
Wikidata

© 2026 theSindex. All rights reserved.

Home
Authors
Moses M. Kasembeli

Moses M. Kasembeli

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution”.

Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution

Pharmacological Reviews(2020)10.1124/pr.119.018440

N/A

0DataRank · unranked

306 citations

Moses M. Kasembeli, Prema Robinson, David J. Tweardy, Uddalak Bharadwaj

TTI-101: A competitive inhibitor of STAT3 that spares oxidative phosphorylation and reverses mechanical allodynia in mouse models of neuropathic pain

Biochemical Pharmacology(2021)10.1016/j.bcp.2021.114688

N/A

0DataRank · unranked

47 citations

Pooja Singhmar, Jiacheng Ma, Jules D. Edralin, Yongfu Tang, Clydell Adams +4 more

Novel STAT3 small-molecule inhibitors identified by structure-based virtual ligand screening incorporating SH2 domain flexibility

Pharmacological Research(2021)10.1016/j.phrs.2021.105637

N/A

0DataRank · unranked

22 citations

Uddalak Bharadwaj, T. Kris Eckols, Mikhail Kolosov, Haoyi Wu, Francisco J. Santa Cruz-Pavlovich +7 more

Corrigendum to “TTI-101: A competitive inhibitor of STAT3 that spares oxidative phosphorylation and reverses mechanical allodynia in mouse models of neuropathic pain” [Biochem. Pharmacol. 192 (2021) 114688]

Biochemical Pharmacology(2021)10.1016/j.bcp.2021.114860

N/A

0DataRank · unranked

2 citations

Pooja Singhmar, Jiacheng Ma, Jules D. Edralin, Yongfu Tang, Clydell Adams +4 more

Blockade of the PD-1/PD-L1 Immune Checkpoint Pathway Improves Infection Outcomes and Enhances Fungicidal Host Defense in a Murine Model of Invasive Pulmonary Mucormycosis

Frontiers in Immunology(2022)10.3389/fimmu.2022.838344

N/A

0DataRank · unranked

61 citations

Nathaniel D. Albert, Uddalak Bharadwaj, Moses M. Kasembeli, Jeffrey J. Tarrand, Naval Daver +2 more

IL-6 predicts CDK4/6 inhibitor resistance, identifying STAT3 as a target in HR + /HER2-negative metastatic breast cancer

npj Precision Oncology(2025)10.1038/s41698-025-01041-1

N/A

0DataRank · unranked

14 citations

Tuyen Bui, Juliana Navarro-Yepes, Sanaz Ghotbaldini, Bethanie Quintela, Catherine K. Luo +19 more

STAT3 Inhibition to Treat Ulcerative Colitis-Associated Colorectal Cancer

International Journal of Molecular Sciences(2025)10.3390/ijms262110808

N/A

0DataRank · unranked

2 citations

Zal Italia, Zara Italia, Tan Hoang, Emma Rodrı́guez, T. Kris Eckols +6 more

Selective inhibition of canonical STAT3 signaling suppresses K-ras mutant lung tumorigenesis and reinvigorates anti-tumor immunity

Frontiers in Immunology(2025)10.3389/fimmu.2025.1575181

N/A

0DataRank · unranked

0 citations

Zahraa Rahal, Sung-Nam Cho, Avantika Krishna, Bo Yuan, Leticia G Hamana Zorrilla +22 more